Abbott is trading at $108.43, up 5.73%, with no verified company-specific announcement or late-breaking catalyst explaining the after-hours move.
- The stock rose from the September 18 regular-session close of $102.61.
- Recent coverage centers on Abbott’s nearly $385 million infant-formula settlement, announced September 14, which does not clearly explain the upward movement.
- Broader market support was modest: Nasdaq up 0.80% and S&P 500 up 0.27%.